Results 111 to 120 of about 18,985 (204)

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid

open access: yes, 2002
peer reviewedBisphosphonate drugs inhibit osteoclastic bone resorption and are widely used to treat skeletal complications in patients with tumor-induced osteolysis.
Bonjean, Karine   +7 more
core   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Zoledronic acid for chronic kidney disease-associated osteoporosis. [PDF]

open access: yesArch Osteoporos
Sakthivel S   +4 more
europepmc   +1 more source

Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly

open access: yes, 2018
Chen Shi,1,* Mi Zhang,2,* An-Yuan Cheng,1 Zi-Feng Huang1 1Department of Trauma Surgery, Wuhan No 1 Hospital, Wuhan, China; 2Department of Orthopedics, Wuhan No 5 Hospital, Wuhan, China *These authors contributed equally to this work Objective: We
Cheng AY, Shi C, Zhang M, Huang ZF
core  

Bisphosphonate (Zoledronic Acid) Associated Adverse Events: Single Center Experience

open access: yes, 2010
Zoledronic acid is an efficacy-proven bisphosphonate used in the patients who develop bone metastasis. In our study, we planned to evaluate side effects occurring in the patients who receive zoledronic acid.
Uslu, Ruchan   +8 more
core  

Fanconi syndrome induced by zoledronic acid: Two case reports. [PDF]

open access: yesMedicine (Baltimore)
Chen Y   +5 more
europepmc   +1 more source

TSH suppression attenuates the early efficacy of zoledronic acid in osteoporosis. [PDF]

open access: yesArch Osteoporos
Liu Y   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy